ACC 2011: MAGELLAN

Updated:Mar 25,2015
AHA Science News from ACC.11
MAGELLAN
Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
Alexander T. Cohen, MD, Bayer HealthCare AG, Leverkusen, Germany

 



ACC 2011: Navigation

Science News from ACC 2011 - Home
Sunday, April 3
PARTNERPARTNER Cohort B
 
Monday, April 4
PRECOMBAT
EVEREST II
STICH
STICH Viability
RAPS
ISAR-CABG
RIVAL
RESOLUTE US
PLATINUM
REMEDIAL II
 
Tuesday, April 5
MAGELLAN
OSCAR
NAGOYA HEART Study
PROTECTION-AMI
EXCELLENT
 
TARGET Study
Rheos Trial
PROACT
AF Clinic
Danish Heart Failure Study
 
Science News Videos
Click on the link below to view complete video coverage from ACC 2011.  Plus, search all AHA/ASA Science news video archives.

acc11_sn_youtube2_button